AIM Health Group Inc.

President of ROMlight International Inc., both shareholders of MedEmerg will join the board of AIM Health Group Inc. following completion of the transaction. The deal is also subject to customary regulatory and court approvals, including the listing approval of the TSX Venture Exchange. The special committee appointed by the Board of Directors of Med-Emerg International Inc. has unanimously recommended the deal and the Board of Directors have approved the deal. Genuity Capital Markets acted as financial advisor for Med-Emerg International Inc. Equity Transfer & Trust Company acted as depository for AIM Health. Will Fung of Blake, Cassels & Graydon LLP acted as legal advisor for AIM Health. Richard J. Steinberg of Fasken Martineau DuMoulin LLP acted as legal advisor for Med-Emerg International.  On January 8, 2009, the transaction received approval of the shareholders of Med-Emerg International Inc. The completion of the transaction remains subject to court approval and satisfaction of certain additional closing conditions. On January 13, 2009, the transaction received the court approval. Subject to the satisfaction of certain closing conditions, the transaction is expected to close on or about January 15, 2009.  AIM Health Group Inc. (TSXV: AH G) completed the acquisition of Med-Emerg International Inc. (OTCBB: MDER) from Calian Technologies Ltd. (TSX: CTY) and other shareholders on January 20, 2009.